Monday, May 20, 2019

Actuate Therapeutics Finds $21.7M

Fort Worth-based Actuate Therapeutics, a clinical stage biopharmaceuticals company which is developing treatments for cancer and inflammatory disease, has raised $21.7M in a Series B funding round

The story you have requested is only available to paid members of the TEXASTECHPULSE web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.